<DOC>
	<DOCNO>NCT02280772</DOCNO>
	<brief_summary>Glucomannan ( GNN ) , water-soluble dietary fiber derive plant Amorphophallus konjac , market weight reduction . The exact mechanism GNN might exert action unclear . Nonetheless , show GNN slow gastric empty form viscous gel large volume , increase feel satiety . Current evidence effectiveness GNN weight reduction sparse , well-designed trial perform child need ass efficacy modality . We aim systematically evaluate efficacy GNN consumption management overweight obesity child .</brief_summary>
	<brief_title>Effect Glucomannan Supplementation Body Weight Overweight Obese Children</brief_title>
	<detailed_description>Methods analysis Children age 6 17 year overweight obesity ( base WHO growth criterion ) randomly assign receive GNN placebo ( maltodextrin ) ( dose 3 g/day ) 3 month follow 3 month . Prior intervention , child receive dietetic advice , encourage engage physical activity . The primary outcome measure BMI-for-age z-score difference group end intervention .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>( 1-6 ) -alpha-glucomannan</mesh_term>
	<criteria>age 617 year ; overweight obesity base WHO growth charts/references ( &gt; +1 standard deviation [ SD ] &gt; +2 SD , respectively ) drug therapy chronic disease ( include drug influence appetite body weight ) ; type 1 2 diabetes ; history surgical treatment obesity ; participation another program treating obesity project and/or 3 month prior recruitment ; secondary cause obesity ; pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>glucomannan</keyword>
	<keyword>obesity</keyword>
	<keyword>child</keyword>
	<keyword>overweight</keyword>
	<keyword>adolescent</keyword>
	<keyword>treatment</keyword>
</DOC>